ArticleIntervirology2022

Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays.

Farah M Shurrab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.